Ara
Toplam kayıt 1, listelenen: 1-1
Cardiotoxicity of Trastuzumab Emtansine (T-DM1): A Single-center Experience
(2021)
Objective New anti-cancer drugs promise to increased survival benefits and reduce adverse events. Trastuzumab emtansine (T-DM1) is a novel anti-human epidermal growth factor receptor 2 agent that has shown minimal ...